Doctor of Dentistry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Adam Hogan

Dentist, General Practice Virginia Beach, VA Doctor of Dentistry

NPI 1518939776 CMS profile 159829

2021 Pleasure House Rd, Virginia Beach, VA 23455

Open in the dashboard

General payments

$49,467

189 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Adam Hogan of Virginia Beach, VA is reported in the CMS Open Payments database as having received $49,467 across 189 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Dentist, General Practice profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $384 10
2024 General $29,912 37
2023 General $7,637 35
2022 General $3,545 37
2021 General $3,973 38
2020 General $997 13
2019 General $3,019 19

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Adam Hogan
  • Dentist, General Practice median
  • Middle half of Dentist, General Practice
  • National median

In program year 2025, general payments to Adam Hogan were reported at $384. Among 41,122 Dentist, General Practice profiles paid that year, the median was $75 and the middle half received between $27 and $200.

Show as a table
Year Adam Hogan Dentist, General Practice median Middle half National median
2019 $3,019 $61 $23–$158 $163
2020 $997 $73 $24–$142 $114
2021 $3,973 $75 $25–$184 $132
2022 $3,545 $75 $27–$198 $149
2023 $7,637 $77 $28–$200 $160
2024 $29,912 $74 $27–$187 $164
2025 $384 $75 $27–$200 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Straumann USA LLC $46,302 168 payments
  2. Midmark Corporation $1,743 2 payments
  3. A-dec, Inc. $748 4 payments
  4. Zimvie Inc. $203 3 payments
  5. BioHorizons Implant Systems Inc. $157 3 payments
  6. 3M Company $114 4 payments
  7. Salvin Dental Specialties, Inc. $109 1 payment
  8. Keystone Dental Inc. $52 1 payment
  9. Carestream Dental, LLC $25 2 payments
  10. Dentsply Sirona Inc $13 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $22,912 6 payments
  2. Honoraria $8,500 3 payments
  3. Food and Beverage $7,608 133 payments
  4. Travel and Lodging $5,212 4 payments
  5. Gift $4,850 33 payments
  6. Entertainment $385 10 payments
Products named General payments · program years 2019–2025
  1. T3 $130 1 payment
  2. BioHorizons Dental Implants $83 2 payments
  3. BIOHORIZONS Implant Dentistry $74 1 payment
  4. BIOHORIZONS Implant Dentistry $74 1 payment
  5. BIOHORIZONS Implant Dentistry $74 1 payment
  6. BIOHORIZONS Implant Dentistry $74 1 payment
  7. BIOHORIZONS Implant Dentistry $74 1 payment
  8. 3i T3 $73 2 payments
  9. Filtek Universal Restorative $58 2 payments
  10. Scotchbond Universal Adhesive $56 2 payments
  11. Other $170 6 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

145

Median for Dentist: 47

Drug cost

$939

Median for Dentist: $159

Branded share of claims

39.3%

Median for Dentist: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 21 $352
Methylprednisolone Generic 17 $130
Cyclobenzaprine Hcl Generic 14 $102
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 19 $80
Amoxicillin Generic 21 $79
Vitamin D2 Ergocalciferol (Vitamin D2) Brand 17 $74
Ibuprofen Generic 23 $68
Chlorhexidine Gluconate Generic 13 $54

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 110,731 Part D prescribers listed as Dentist; they describe a distribution and say nothing about conduct.

Records

189 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dentist, General Practice in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record